4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Predicting neurodevelopmental risk in children born to mothers living with HIV in Kenya: protocol for a prospective cohort study (Tabiri Study)

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          For the growing number of children with in utero and postpartum exposure to HIV and/or antiretrovirals, it is unclear which exposures or risk factors play a significant role in predicting worse neurodevelopmental outcomes. This protocol describes a prospective longitudinal cohort study of infants born to mothers living with HIV and those born to mothers without HIV. We will determine which risk factors are most predictive of child neurodevelopment at 24 months. We aim to create a risk assessment tool to help predict which children are at risk for worse neurodevelopment outcomes.

          Methods and analysis

          This study leverages an existing Kenyan cohort to prospectively enrol 500 children born to mothers living with HIV and 500 to those without HIV (n=1000 total) and follow them from birth to age 24 months. The following factors will be measured every 6 months: infectious morbidity and biological/sociodemographic/psychosocial risk factors. We will compare these factors between the two groups. We will then measure and compare neurodevelopment within children in both groups at 24 months of age using the Child Behaviour Checklist and the Bayley Scales of Infant and Toddler Development, third edition. Finally, we will use generalised linear mixed modelling to quantify associations with neurodevelopment and create a risk assessment tool for children ≤24 months.

          Ethics and dissemination

          The study is approved by the Moi University’s Institutional Research and Ethics Committee (IREC/2021/55; Approval #0003892), Kenya’s National Commission for Science, Technology and Innovation (NACOSTI, Reference #700244) and Indiana University’s Institutional Review Board (IRB Protocol #110990). This study carries minimal risk to the children and their mothers, and all mothers will provide written consent for participation in the study. Results will be disseminated to maternal child health clinics within Uasin Gishu County, Kenya and via papers submitted to peer-reviewed journals and presentation at international conferences.

          Related collections

          Most cited references45

          • Record: found
          • Abstract: not found
          • Article: not found

          Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The PHQ-9: validity of a brief depression severity measure.

            While considerable attention has focused on improving the detection of depression, assessment of severity is also important in guiding treatment decisions. Therefore, we examined the validity of a brief, new measure of depression severity. The Patient Health Questionnaire (PHQ) is a self-administered version of the PRIME-MD diagnostic instrument for common mental disorders. The PHQ-9 is the depression module, which scores each of the 9 DSM-IV criteria as "0" (not at all) to "3" (nearly every day). The PHQ-9 was completed by 6,000 patients in 8 primary care clinics and 7 obstetrics-gynecology clinics. Construct validity was assessed using the 20-item Short-Form General Health Survey, self-reported sick days and clinic visits, and symptom-related difficulty. Criterion validity was assessed against an independent structured mental health professional (MHP) interview in a sample of 580 patients. As PHQ-9 depression severity increased, there was a substantial decrease in functional status on all 6 SF-20 subscales. Also, symptom-related difficulty, sick days, and health care utilization increased. Using the MHP reinterview as the criterion standard, a PHQ-9 score > or =10 had a sensitivity of 88% and a specificity of 88% for major depression. PHQ-9 scores of 5, 10, 15, and 20 represented mild, moderate, moderately severe, and severe depression, respectively. Results were similar in the primary care and obstetrics-gynecology samples. In addition to making criteria-based diagnoses of depressive disorders, the PHQ-9 is also a reliable and valid measure of depression severity. These characteristics plus its brevity make the PHQ-9 a useful clinical and research tool.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Inequality in early childhood: risk and protective factors for early child development.

              Inequality between and within populations has origins in adverse early experiences. Developmental neuroscience shows how early biological and psychosocial experiences affect brain development. We previously identified inadequate cognitive stimulation, stunting, iodine deficiency, and iron-deficiency anaemia as key risks that prevent millions of young children from attaining their developmental potential. Recent research emphasises the importance of these risks, strengthens the evidence for other risk factors including intrauterine growth restriction, malaria, lead exposure, HIV infection, maternal depression, institutionalisation, and exposure to societal violence, and identifies protective factors such as breastfeeding and maternal education. Evidence on risks resulting from prenatal maternal nutrition, maternal stress, and families affected with HIV is emerging. Interventions are urgently needed to reduce children's risk exposure and to promote development in affected children. Our goal is to provide information to help the setting of priorities for early child development programmes and policies to benefit the world's poorest children and reduce persistent inequalities. Copyright © 2011 Elsevier Ltd. All rights reserved.
                Bookmark

                Author and article information

                Journal
                BMJ Open
                BMJ Open
                bmjopen
                bmjopen
                BMJ Open
                BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
                2044-6055
                2022
                3 April 2022
                : 12
                : 4
                : e061051
                Affiliations
                [1 ]departmentDepartment of Medical Physiology , Moi University College of Health Sciences , Eldoret, Kenya
                [2 ]Academic Model Providing Access to Healthcare , Eldoret, Kenya
                [3 ]departmentDepartment of Emergency Medicine , American University of Beirut , Beirut, Lebanon
                [4 ]departmentArnold Institute for Global Health , Icahn School of Medicine at Mount Sinai , New York, New York, USA
                [5 ]departmentDepartment of Child Health , Moi University College of Health Sciences , Eldoret, Kenya
                [6 ]departmentDepartment of Biostatistics , Indiana University School of Medicine , Indianapolis, Indiana, USA
                [7 ]departmentDepartment of Pediatrics , Indiana University School of Medicine , Indianapolis, Indiana, USA
                [8 ]departmentDepartment of Clinical Pharmacology , Indiana University School of Medicine , Indianapolis, Indiana, USA
                [9 ]departmentDepartment of Paediatrics & Child Health, Faculty of Medicine & Health Sciences , Stellenbosch University , Stellenbosch, South Africa
                [10 ]departmentDepartment of Medicine , Indiana University School of Medicine , Indianapolis, Indiana, USA
                [11 ]departmentDivision of Obstetrics and Gynecology , Moi University College of Health Sciences , Eldoret, Kenya
                [12 ]University of Washington School of Medicine , Seattle, Washington, USA
                Author notes
                [Correspondence to ] Megan S McHenry; msuhl@ 123456iupui.edu
                Author information
                http://orcid.org/0000-0002-5538-1694
                http://orcid.org/0000-0001-9893-5856
                http://orcid.org/0000-0001-6753-0928
                Article
                bmjopen-2022-061051
                10.1136/bmjopen-2022-061051
                8981283
                35379648
                8982dfc8-96c8-4418-8911-90e2d69b8915
                © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

                This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:  http://creativecommons.org/licenses/by-nc/4.0/.

                History
                : 20 January 2022
                : 02 March 2022
                Funding
                Funded by: National Institutes of Health (NIH);
                Award ID: R01HD104552
                Funded by: NIH;
                Award ID: U01AI069911
                Categories
                Paediatrics
                1506
                1719
                Protocol
                Custom metadata
                unlocked

                Medicine
                hiv & aids,infectious disease/hiv,paediatrics,delirium & cognitive disorders
                Medicine
                hiv & aids, infectious disease/hiv, paediatrics, delirium & cognitive disorders

                Comments

                Comment on this article